Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
8.68
+0.43 (5.21%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Pharming Group Revenue

Pharming Group had revenue of $74.85M in the quarter ending September 30, 2024, with 12.22% growth. This brings the company's revenue in the last twelve months to $285.75M, up 30.64% year-over-year. In the year 2023, Pharming Group had annual revenue of $245.32M with 19.30% growth.

Revenue (ttm)
$285.75M
Revenue Growth
+30.64%
P/S Ratio
n/a
Revenue / Employee
$748,024
Employees
382
Market Cap
592.04M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023245.32M39.69M19.30%
Dec 31, 2022205.62M6.75M3.39%
Dec 31, 2021198.87M-13.30M-6.27%
Dec 31, 2020212.17M22.79M12.03%
Jan 1, 2020189.39M54.26M40.15%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Orthofix Medical 771.65M
Fulgent Genetics 290.71M
Entrada Therapeutics 239.40M
Axogen 173.48M
Simulations Plus 70.01M
Q32 Bio -12.80M
Revenue Rankings